Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd] · Class II · Cleared Mar 4, 2021
| K-number | K203193 |
| Device name | BD Intraosseous Infusion System |
| Applicant | Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd] |
| Product code | MHC |
| Device class | Class II |
| Decision date | Mar 4, 2021 |
| Decision | Substantially Equivalent |
| Regulation | 880.5570 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov